European Healthtech startup funding raised during 2011.
In 2011, 63 European Healthtech companies raised a combined €530M across 66 funding rounds. Switzerland led by capital raised, and Sunstone Capital was the most active investor. Data as of 7 Aug 2026.
3 exits · €1.0B disclosed.
| BioVex | Acquisition | Jan 2011 | €909M |
| Advanced Accelerator Applications | Buyout | Oct 2011 | €41M |
| Apr 2011 |
| €28M |
| AFFiRiS | Growth/Late | Nov 2011 | €25M |
| Sphere Medical Holding | Growth/Late | Oct 2011 | €18M |
| Anergis | Series A | Mar 2011 | €14M |
| Orphazyme | Series A | Sep 2011 | €14M |
| GenKyoTex | Series C | May 2011 | €14M |
| BONESUPPORT | Growth/Late | Jun 2011 | €13M |
| LifeBond | Series C | May 2011 | €13M |
| Sapiens | Series A | Jun 2011 | €13M |
| uTest_Vamsi | Series D+ | Dec 2011 | €13M |
| OrSense | Growth/Late | May 2011 | €12M |
| MyoPowers Medical Technologies | Series B | Jul 2011 | €11M |
